209 related articles for article (PubMed ID: 21112041)
1. Immunophenotyping in multiple myeloma and related plasma cell disorders.
Kumar S; Kimlinger T; Morice W
Best Pract Res Clin Haematol; 2010 Sep; 23(3):433-51. PubMed ID: 21112041
[TBL] [Abstract][Full Text] [Related]
2. Clinical challenges: Myeloma and concomitant type 2 diabetes.
Ali MA; Ahmed YA; Ibrahim A
South Asian J Cancer; 2013 Oct; 2(4):290-5. PubMed ID: 24455664
[TBL] [Abstract][Full Text] [Related]
3. The genetic architecture of multiple myeloma.
Morgan GJ; Walker BA; Davies FE
Nat Rev Cancer; 2012 Apr; 12(5):335-48. PubMed ID: 22495321
[TBL] [Abstract][Full Text] [Related]
4. Differentiation stage of myeloma plasma cells: biological and clinical significance.
Paiva B; Puig N; Cedena MT; de Jong BG; Ruiz Y; Rapado I; Martinez-Lopez J; Cordon L; Alignani D; Delgado JA; van Zelm MC; Van Dongen JJ; Pascual M; Agirre X; Prosper F; Martín-Subero JI; Vidriales MB; Gutierrez NC; Hernandez MT; Oriol A; Echeveste MA; Gonzalez Y; Johnson SK; Epstein J; Barlogie B; Morgan GJ; Orfao A; Blade J; Mateos MV; Lahuerta JJ; San-Miguel JF
Leukemia; 2017 Feb; 31(2):382-392. PubMed ID: 27479184
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of antigen expression in multiple myeloma: a PETHEMA/GEM study on 1265 patients enrolled in four consecutive clinical trials.
Arana P; Paiva B; Cedena MT; Puig N; Cordon L; Vidriales MB; Gutierrez NC; Chiodi F; Burgos L; Anglada LL; Martinez-Lopez J; Hernandez MT; Teruel AI; Gironella M; Echeveste MA; Rosiñol L; Martinez R; Oriol A; De la Rubia J; Orfao A; Blade J; Lahuerta JJ; Mateos MV; San Miguel JF
Leukemia; 2018 Apr; 32(4):971-978. PubMed ID: 29099494
[TBL] [Abstract][Full Text] [Related]
6. Absence of both CD56 and CD117 expression on malignant plasma cells is related with a poor prognosis in patients with newly diagnosed multiple myeloma.
Pan Y; Wang H; Tao Q; Zhang C; Yang D; Qin H; Xiong S; Tao L; Wu F; Zhang J; Zhai Z
Leuk Res; 2016 Jan; 40():77-82. PubMed ID: 26597998
[TBL] [Abstract][Full Text] [Related]
7. The prognostic impact of multiparameter flow cytometry immunophenotyping and cytogenetic aberrancies in patients with multiple myeloma.
Guo J; Su J; He Q; Li X; Zhao Y; Gu S; Fei C; Chang C
Hematology; 2016 Apr; 21(3):152-61. PubMed ID: 25860485
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases.
Tembhare PR; Yuan CM; Venzon D; Braylan R; Korde N; Manasanch E; Zuchlinsky D; Calvo K; Kurlander R; Bhutani M; Tageja N; Maric I; Mulquin M; Roschewski M; Kwok M; Liewehr D; Landgren O; Stetler-Stevenson M
Leuk Res; 2014 Mar; 38(3):371-6. PubMed ID: 24462038
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma.
Flores-Montero J; de Tute R; Paiva B; Perez JJ; Böttcher S; Wind H; Sanoja L; Puig N; Lecrevisse Q; Vidriales MB; van Dongen JJ; Orfao A
Cytometry B Clin Cytom; 2016 Jan; 90(1):61-72. PubMed ID: 26100534
[TBL] [Abstract][Full Text] [Related]
10. Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide.
Kawano Y; Fujiwara S; Wada N; Izaki M; Yuki H; Okuno Y; Iyama K; Yamasaki H; Sakai A; Mitsuya H; Hata H
Int J Oncol; 2012 Sep; 41(3):876-84. PubMed ID: 22766978
[TBL] [Abstract][Full Text] [Related]
11. Liquid Biopsies as Non-Invasive Tools for Mutation Profiling in Multiple Myeloma: Application Potential, Challenges, and Opportunities.
Heestermans R; Schots R; De Becker A; Van Riet I
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791247
[TBL] [Abstract][Full Text] [Related]
12. Mass spectrometry-based methods for investigating the dynamics and organization of the surfaceome: exploring potential clinical implications.
Xu X; Yin K; Xu S; Wang Z; Wu R
Expert Rev Proteomics; 2024; 21(1-3):99-113. PubMed ID: 38300624
[TBL] [Abstract][Full Text] [Related]
13. Predicting cell types with supervised contrastive learning on cells and their types.
Heryanto YD; Zhang YZ; Imoto S
Sci Rep; 2024 Jan; 14(1):430. PubMed ID: 38172501
[TBL] [Abstract][Full Text] [Related]
14. Flow Cytometry as a Diagnostic Tool in Monoclonal Gammopathy of Renal Significance.
Rath A; Dass J; Viswanathan GK; Dhawan R; Aggarwal M; Mahapatra M
Indian J Nephrol; 2023; 33(4):321-323. PubMed ID: 37781544
[No Abstract] [Full Text] [Related]
15. Immunophenotypic Profile of Multiple Myeloma: A Tertiary Care Centre Experience.
Rath A; Panda T; Dass J; Seth T; Mahapatra M; Tyagi S
J Lab Physicians; 2023 Sep; 15(3):392-398. PubMed ID: 37564229
[No Abstract] [Full Text] [Related]
16. Immunophenotypic expression profile of multiple myeloma cases at a tertiary hospital in Nairobi Kenya.
Mengich I; Rajput S; Malkit R; Moloo Z; Kagotho E; Lalani EN; Mwirigi A
Front Med (Lausanne); 2023; 10():1177775. PubMed ID: 37250623
[TBL] [Abstract][Full Text] [Related]
17. Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma.
Baughn LB; Jessen E; Sharma N; Tang H; Smadbeck JB; Long MD; Pearce K; Smith M; Dasari S; Sachs Z; Linden MA; Cook J; Keith Stewart A; Chesi M; Mitra A; Leif Bergsagel P; Van Ness B; Kumar SK
Blood Cancer J; 2023 May; 13(1):84. PubMed ID: 37217482
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk in the diseased plasma cell niche - the force of inflammation.
Schäfer AL; Ruiz-Aparicio PF; Kraemer AN; Chevalier N
Front Immunol; 2023; 14():1120398. PubMed ID: 36895566
[No Abstract] [Full Text] [Related]
19. Chimeric antigen receptor T (CAR-T) cells: Novel cell therapy for hematological malignancies.
Abbasi S; Totmaj MA; Abbasi M; Hajazimian S; Goleij P; Behroozi J; Shademan B; Isazadeh A; Baradaran B
Cancer Med; 2023 Apr; 12(7):7844-7858. PubMed ID: 36583504
[TBL] [Abstract][Full Text] [Related]
20. Dual Negativity of CD56 and CD117 Links to Unfavorable Cytogenetic Abnormalities and Predicts Poor Prognosis in Multiple Myeloma.
Zheng D; Zhu M; Li Q; Wan W; Chen Y; Jing H
J Clin Med; 2022 Nov; 11(21):. PubMed ID: 36362752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
